Stock Market News for April 3, 2026

Markets & capital raises

OwlTing Group (OWLS) secured a US$10 million investment with up to US$50 million available by mutual consent. That infusion can extend runway for operational scaling; investors will watch for equity terms and dilution details in follow-up filings.

Wix (WIX) released the final results of its modified Dutch auction tender offer. Completion of buybacks tightens the float and can lift per-share metrics if growth holds.

Ridgetech, Inc. (CJJD) announced a 1-for-150 reverse share split. Such consolidation often aims to meet listing criteria or improve bid-price optics, but it also concentrates ownership and can precede other liquidity events.

Earnings & results

Apogee Enterprises (APOG) set the date for fiscal 2026 fourth-quarter and full-year results. Scheduled earnings can reset expectations for guidance and capital allocation plans.

RCM Technologies (RCMT) announced fourth-quarter and fiscal 2025 results. Quarterly results remain the immediate driver of short-term price action, especially for industrial and services names where backlog and margin trends matter.

Strategic Storage Trust VI, Inc. (SMA) reported year-ended December 31, 2025 results in a year-end filing. REIT operational metrics and occupancy trends will be the focus for investors assessing cash returns and dividend coverage.

Corporate leadership and governance

Village Farms (VFF) announced a succession plan for its CFO. Clear transitions reduce uncertainty around financial strategy and reporting cadence.

NeuroSense Therapeutics (NRSN) received Nasdaq notifications about minimum bid price and market value requirements. Compliance notices can pressure microcaps to act quickly on reverse splits, capital raises or uplisting plans.

ArcelorMittal (MT) published a convening notice for its AGM and an extraordinary meeting on 5 May 2026. Watch for agenda items that could shape dividends or capital allocation at the steel major.

Biotech and clinical milestones

Denali Therapeutics (DNLI) regained full rights to investigational therapy DNL593 (PTV:PGRN) for GRN‑related frontotemporal dementia. Regained rights can accelerate development timelines and clarify partnership or royalty prospects—important for pipeline valuation.

Impact BioMedical Inc. (IBO) reported a going-concern audit opinion in its 2025 10‑K while pursuing strategic merger plans. A going‑concern flag raises near-term liquidity risk and makes merger outcomes material to current shareholders.

Agenus (AGEN) said Phase II data for BOT+BAL with agent‑797 in PD‑1 refractory gastroesophageal cancer will be presented at AACR 2026. Clinical readouts can be catalysts if response rates or durability beat expectations.

Shipping and energy fleet moves

Hafnia (HAFN) signed a newbuild agreement for eight MR product tankers. Fleet expansion bets on product tanker demand but adds near-term capex and delivery timing to monitor.

Geronimo Power / First Solar (FSLR) announced the start of operations at the Dodson Creek solar project in Ohio. Grid‑connected solar starts boost contracted revenue visibility and support renewable growth narratives for utilities and developers.

Tech, data and operations

Figure Technology Solutions (FIGR) posted preliminary March and Q1 operating data. Early reads help investors size momentum ahead of formal earnings—watch volume and margin trends.

EV charging and infrastructure

XCharge North America (XCH) and JOJO Superfast launched a Midwest EV charging deployment. Network expansion supports EV adoption and recurring revenue potential for operators.

Consumer & real estate

KB Home (KBH) opened Linwood at Madera Ranch with homes starting in the $370Ks. New community launches give a read on local demand and pricing power in entry-level segments.

Partnerships and branding

LEIFRAS Co., Ltd. (LFS) marked its appointment as an official partner of the Japan Sport Association in a signing ceremony. Sponsorships can expand regional visibility and B2B channels.

• What to watch next: terms of OwlTing’s financing and any dilution, delivery schedule and margin impact from Hafnia’s newbuilds, final Q1 results from Figure, regulatory steps or reverse-split actions tied to NeuroSense and Ridgetech, and investor reaction to Denali’s regained rights and Impact BioMedical’s going‑concern filing.